Overview

Epinomics provided an epigenomics platform that uses ATAC-seq to map chromatin accessibility and gene regulation from a small number of cells, supporting drug development and biomarker discovery. It combines this high-sensitivity epigenomic assay with a data analytics engine to interpret regulatory patterns and predict responses in areas like immuno-oncology. The company stood out by delivering cell-efficient, high-resolution epigenetic insights through collaborations with pharma, biotech, and academia. Its goal was to speed therapeutic development and biomarker discovery by turning dynamic epigenetic data into actionable insights, and its team/technology were later integrated into 10x Genomics’ Chromium Single Cell ATAC Solution.